Deadline: 27-Mar-23
The Centers for Disease Control (CGH) is offering grants for Strengthening Local Capacity to Deliver Comprehensive HIV/AIDS Prevention, Care and Treatment Activities in the Republic of Côte d’Ivoire under the President’s Emergency Plan for AIDS Relief (PEPFAR).
Health Priorities and Strategies
- Prevention (HHS/CDC) works in partnership with host country governments and other key partners to assess the needs of each country and design a customized program of assistance that fits within the host nation’s strategic plan in a manner consistent with the purposes of this NOFO. Goals and priorities include the following:
- Reducing the prevention and treatment gaps for adolescent girls and young women (AGYW), children, and key populations (KP);
- Strengthening national and local programmatic, financial, and community leadership;
- Designing new partnerships with key private, public, and multi sector entities that can complement existing programs and expand reach;
- Utilizing the PEPFAR platform for broader disease surveillance and public health programming, consistent with the PEPFAR legislative and funding authority;
- Investing in the scale-up of cutting edge behavioral, and implementation science to bend the curve on new infections;
- Improving the care and treatment of HIV/AIDS, sexually transmitted infections (STIs), and related opportunistic infections by improving STI management; enhancing laboratory diagnostic capacity and the care and treatment of opportunistic infections; interventions for intercurrent diseases impacting HIV infected patients including tuberculosis (TB); and initiating programs to provide anti-retroviral therapy (ART);
- Strengthening the capacity of countries to collect, use, and share surveillance data and manage national HIV/AIDS programs by expanding HIV/STI/TB surveillance programs and strengthening laboratory support for surveillance, diagnosis, treatment, disease monitoring, and HIV screening for blood safety; and
- Developing, validating, and/or evaluating public health programs to inform, improve, and target appropriate interventions, as related to the prevention, care and treatment of HIV/AIDS, TB, and opportunistic infections.
- In an effort to ensure maximum cost efficiencies and program effectiveness, HHS/CDC also supports coordination with and among relevant partners. Recipients may be requested to participate in the following programmatic activities:
- Scale-up evidence-based programs to identify and close the major HIV gaps among AGYW, children, and key populations;
- Increase impact through strategic coordination and integration;
- Strengthen and leverage key multilateral organizations, global health partnerships, and private sector engagement;
- Encourage country ownership and invest in country-led plans, putting our national and local partners in the lead and actively enabling their growth through design of the program at all phases;
- Build sustainability through investments in health systems;
- Enhance health equity and reduce disparities in access to and uptake of HIV services;
- Improve performance metrics, monitoring and evaluation and the quality of related data; and
- Promote research, development, and innovation to develop a body of knowledge, enhance awareness and increase the skills and abilities of stakeholders (research is not supported by this NOFO).
- Strategies
- Strategy 1: Implement efficient HIV/TB case finding approaches to identify, link and initiate PLHIV sub-populations to treatment and prevention.
- Strategy 2: Implement comprehensive HIV/TB services for AGYW, OVC and other priority populations.
- Strategy 3: Scale and sustain solutions to address barriers to HIV/TB treatment continuity for adults, children, KP and priority subpopulations.
- Strategy 4: Scale and sustain solutions to address barriers to VLC and VLS among specific populations.
- Strategy 5: Provide targeted technical assistance to MSHPCMU to facilitate transition and sustainability of HIV/TB services.
Funding Information
- Average One Year Award Amount: $25,000,000
- Approximate Number of Awards 4
- Total Period of Performance Length: 5 year(s)
- Estimated Award Date: September 30, 2023
Outcomes
- CDC may require or allow applicants to propose additional related project period outcomes other than those identified in the NOFO.
- Short Term Outcomes
- Increased HIV/TB case finding, testing, linkage, and treatment for targeted PLHIV subpopulations
- Increased access to patient-centered quality TB prevention, diagnosis, and treatment services
- Increased knowledge and skills of HCW on KP- and adolescent- and youth-appropriate services, including linkage to DREAMS and OVC programs for AGYW, and infected/affected children/adolescents
- Increased identification of GBV cases and provision of quality post-violence care
- Increased index testing for all biological children and siblings of HIV positive mothers
- Increased identification and timely remediation of ART sites with poor treatment continuity for adults and pediatrics
- Increased identification and timely remediation of PMTCT sites and ART sites with poor VLC and VLS
- Intermediate Outcomes
- Increased yield from family testing and reduced undiagnosed children among HIV infected adults
- Increased access to PrEP and other relevant services among KP, AGYW, and adolescent PBFW
- Improve TPT uptake and coverage
- Increased access to and uptake of comprehensive, multi-sectoral package of core interventions for AGYW, OVC, and priority populations
- Sustained treatment continuity, especially among HIV infected children, men and KP
- Sustained solutions of HIV/TB treatment barriers for adult and pediatric sub-populations
- Sustained implementation of best practices of POC VL use
- Increased and sustained involvement of national government salaried personnel in service delivery to PLHIV
- Long Term Outcomes
- Increased identification, linkage to treatment and ARV initiation for targeted PLHIV subpopulations
- Reduced risk of HIV infection among AGYW, OVC, and other priority populations
- Increased VLC and VLS among PLHIV, including PBFW, infants, and children and KP
- Increased contribution (financial and technical) toward the national HIV response by GoCI
- Short Term Outcomes
Eligibility Criteria
- Eligible Applicants
- Unrestricted
- Additional Eligibility Category:
- Government Organizations:
- State governments or their bona fide agents (includes the District of Columbia)
- Local governments or their bona fide agents
- Territorial governments or their bona fide agents in the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau
- State controlled institutions of higher education
- American Indian or Alaska Native tribal governments
- Government Organizations:
- Non-government Organizations
- American Indian or Alaska native tribally designated organizations
- Other
- Ministries of Health
- Additional Information on Eligibility
- This is a fully competitive NOFO and eligibility is unrestricted, meaning any and all types of organizations and entities are eligible to apply.
- In addition, as may be required by host country laws, applicant is expected to comply with and document that it has satisfied all regulatory requirements of their governing entities that could otherwise compromise the integrity and resources provided by this program or make the conduct of expected activities under this award unable to be performed. Applicants must also meet the criteria established in CDC’s pre-award risk assessment to be eligible to receive funds under this NOFO.
For more information, visit Grants.gov.
